Igor L. Mikheenko

Igor L. Mikheenko

Auto-generated profile, based on publicly available information

Igor L. Mikheenko

Федеральное государственное бюджетное учреждение «Национальный медицинский исследовательский центр имени академика Е.Н. Мешалкина» Министерства здравоохранения Российской Федерации, Новосибирск

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2019 in Heart Rhythm
Verified
Journal Article
Closed access
ARAlexander Romanov
Alexander Romanov
EPEvgeny Pokushalov
Evgeny Pokushalov
DPDmitry Ponomarev
Dmitry Ponomarev
SBSevda Bayramova
Sevda Bayramova
VSVitaliy Shabanov
Vitaliy Shabanov
JSJonathan S. Steinberg
Jonathan S. Steinberg

23 March 2018 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
PDF file
ARAlexander Romanov
Alexander Romanov
EPEvgeny Pokushalov
Evgeny Pokushalov
SBSevda Bayramova
Sevda Bayramova
DPDmitry Ponomarev
Dmitry Ponomarev
VSVitaliy Shabanov
Vitaliy Shabanov
JSJonathan S. Steinberg
Jonathan S. Steinberg

24 April 2023 in Russian Cardiology Bulletin
Verified
Journal Article
Closed access
APAndrey Ponomarenko
Andrey Ponomarenko
YKY.S. Krivosheev
Y.S. Krivosheev
IMI.L. Mikheenko
I.L. Mikheenko
ESE.V. Sorokin
E.V. Sorokin
OSO.V. Sapelnikov
O.V. Sapelnikov
Denis LosikDenis Losik
Denis Losik
Применение сервиса поддержки принятия врачебных решений (СППВР) для работы с большим количеством цифровых данных, таких как электронные медицинские карты (ЭМК), может сыграть важную роль в улучшении качества оказываемой медицинской помощи. ЦЕЛЬ ИССЛЕДОВАНИЯ Оценить перспективы проведения автоматизированного анализа при помощи СППВР соответствия критериев отбора пациентов для катетерной аблации по поводу фибрилляции предсердий (ФП) данным в электронных медицинских картах (ЭМК) среди карт в группах повторной и первичной процедур в реальной клинической практике крупных медицинских центров. МАТЕРИАЛ И МЕТОДЫ Проанализированы ЭМК 232 пациентов, направленных на катетерную аблацию легочных вен по поводу ФП. Основными предикторами рецидива ФП при автоматическом анализе СППВР считались следующие характеристики: возраст, индекс массы тела (ИМТ) и продольный размер левого предсердия (ЛП) по эхокардиографическим данным. РЕЗУЛЬТАТЫ У 137 (59,1%) пациентов, направленных на катетерную аблацию, не имелось предикторов рецидива ФП. Аблация в анамнезе была у 141 (60,8%) пациента. Риск рецидива аритмии выявлен у 49,5% пациентов, направленных на первичную процедуру, и у 36,2% пациентов из группы повторной аблации. ЭМК с прогнозируемым риском рецидива ФП по возрастному критерию составили 14,3% в группе первичной аблации и 5,7% в группе повторной аблации (p=0,026). Доля ЭМК пациентов с прогнозируемым риском рецидива ФП по критерию ИМТ составила 17,6% в группе первичной аблации и 17,7% в группе повторной аблации (p=0,977). Увеличенный размер ЛП был выявлен в качестве прогнозируемого условия рецидива ФП в 26,4% случаев в группе первичной аблации и 18,4% в группе повторной аблации (p=0,152). ЗАКЛЮЧЕНИЕ Среди пациентов с показаниями для катетерной аблации с целью устранения фибрилляции предсердий существенную долю составляют лица с рецидивами аритмии после предыдущих катетерных вмешательств. Отбор пациентов на повторные вмешательства проводится более тщательно. Необходимы современные цифровые инструменты для отбора пациентов на катетерные методы лечения, что может снизить количество повторных процедур и рецидивов ФП.

28 November 2024 in Rational Pharmacotherapy in Cardiology
Verified
Journal Article
Open access
PDF file
K(K. S. Astrakova (Benimetskaya)
K. S. Astrakova (Benimetskaya)
IMI. L. Mikheenko
I. L. Mikheenko
AUA. E. Uranov
A. E. Uranov
AGA. A. Gartung
A. A. Gartung
EKE. A. Kovalev
E. A. Kovalev
PPP. N. Paleev
P. N. Paleev
Aim. To assess the effectiveness of clinical decision support system (CDSS) implementation strategy in increasing the frequency of low-density lipoprotein cholesterol (LDL-С) monitoring in patients hospitalized for acute cardiovascular events (CVEs), in patients with coronary artery disease (CAD) or dyslipidemia.Material and methods. A non-interventional, retrospective, multicentre study assessing the impact of a CDSS with automatic electronic medical record (EMR) data processing on adherence to guidelines in patients at risk of cardiovascular diseases (SuccESS) was performed. The study included two cohorts of patients from healthcare facilities in three regions of Russia. The main cohort consisted of patients hospitalized for acute CVEs, with 12,227 patients included in the first follow-up period and 11,364 patients included in the second follow-up period. The additional cohort consisted of patients with stable CAD or dyslipidemia, with 54 469 patients included in the first follow-up period and 94,616 patients included in the second follow-up period. The study assessed follow-up findings in real-world clinical practice before and after the CDSS was implemented (first and second follow-up periods, respectively). The median duration of follow-up in the main cohort was >158 days in the first follow-up period and >227 days in the second follow-up period.Results. In the second follow-up period the proportion of patients with available data on LDL-C control in the EMR increased from 12.3% to 18.8% (here and further — relative change: +52.3%, p<0.001) in the main cohort and from 12.3% to 19.8% (+61.7%, p<0.001) in the additional cohort. The proportion of patients with myocardial infarction and unstable angina in the main cohort who did not visit a general practitioner or cardiologist during the follow-up period decreased from 33.1% to 25.5% (-23%, p<0.001). The proportion of patients with ischemic stroke and transient ischemic attack (TIA) in the main cohort who did not visit a general practitioner or neurologist during the follow-up period decreased from 66.6% to 39.3% (-41%, p<0.001). In the additional cohort, the proportion of patients who did not visit a general practitioner or cardiologist decreased from 38.2% to 27.6% (-28%, p<0.001). The use of low-intensity/moderate-intensity statin therapy decreased from 12.5% to 9% (-27%, p<0.001) in the main cohort and from 47.4% to 40% (-15%, p<0.001) in the additional cohort. However, the use of high-intensity statin therapy in the additional cohort increased from 42.7% to 49.9% (+17%). In the second follow-up period, there was a decrease in the number of hospitalizations for myocardial infarction and ischemic stroke from 3.6% to 1.7% (-53%, p<0.001) in the main cohort and from 0.1% to 0.06% (-40%, p=0.01) in the additional cohort.Conclusion. The study findings demonstrate the positive impact of CDSS on several parameters that determine the quality and organization of medical care. The CDSS can be used to improve clinical and managerial decisions.

2 April 2021 in Patologiya krovoobrashcheniya i kardiokhirurgiya
Verified
Journal Article
Open access
PDF file
ВБВ. В. Белобородов
В. В. Белобородов
НЕН. А. Елемесов
Н. А. Елемесов
APAndrey Ponomarenko
Andrey Ponomarenko
EME.A. Morzhanaev
E.A. Morzhanaev
АФА. Г. Филиппенко
А. Г. Филиппенко
ARAlexander Romanov
Alexander Romanov
The prevalence of congenital heart diseases is nine persons per 1000. Sometimes, congenital heart disease needs surgical correction. The long-term postoperative period is often associated with complex heart rhythm disturbances like ectopic or re-entry tachycardia. These cases, in combination with difficult anatomy, results in challenges during interventional treatment. Catheter ablation has been demonstrated as safe and effective in different types of arrhythmia treatments in such patients, including paediatric cohorts. Despite these facts, several important problems regarding using current technologies are still unresolved. Remote magnetic navigation showed good results regarding localisation of arrhythmogenic zones during treatment of complex heart rhythm disturbances. The objective of the present article is to review recently published data in this area and experience of Meshalkin National Medical Research Center in heart rhythm disturbances treatment using remote magnetic navigation in patients after surgical correction of congenital heart disease. Received 28 September 2020. Revised 25 December 2020 г. Accepted 30 December 2020. Funding: The study did not have sponsorship. Conflict of interest: Authors declare no conflict of interest. Author contributionsConception and study design: A.B. Romanov, A.M. ChernyavskiyDrafting the article: V.V. Beloborodov, А.V. Ponomarenko, E.А. MorzhanaevCritical revision of the article: A.B. Romanov, А.V. Ponomarenko, I.L. Mikheenko, E.А. Morzhanaev, A.G. Filippenko, A.M. ChernyavskiyFinal approval of the version to be published: V.V. Beloborodov, N.А. Yelemessov, А.V. Ponomarenko, E.А. Morzhanaev, A.G. Filippenko, I.L. Mikheenko, A.M. Chernyavskiy, A.B. Romanov

1 January 2015 in AIP Conference Proceedings
Verified
Conference Paper
Closed access
VEV. U. Efendiev
V. U. Efendiev
SAS. A. Alsov
S. A. Alsov
TRT. M. Ruzmatov
T. M. Ruzmatov
IMI. L. Mikheenko
I. L. Mikheenko
ACA. M. Chernyavsky
A. M. Chernyavsky
EME. S. Malakhov
E. S. Malakhov
A new technology – a thoracoscopic coronary bypass grafting with the use of Da Vinci robotic system in Russia is represented by the experience of NRICP. The technology was introduced in Russia in 2011. Overall, one hundred endoscopic coronary artery bypass procedures were performed. We have compared and analyzed results of coronary artery stenting vs minimally invasive coronary artery bypass grafting. According to the results, totally endoscopic coronary artery bypass grafting has several advantages over alternative treatment strategies.